An analysis of data on 80,000 cancer patients in Sweden showed that regular intake of low-dose aspirin was associated with less advanced disease and smaller tumors in patients with colon and lung cancer. However, the link was not seen in patients with prostate or breast cancer.

Full Story:

Related Summaries